1. Home
  2. PVH vs BEAM Comparison

PVH vs BEAM Comparison

Compare PVH & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PVH Corp.

PVH

PVH Corp.

HOLD

Current Price

$79.73

Market Cap

3.6B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$32.75

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PVH
BEAM
Founded
1881
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.0B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
PVH
BEAM
Price
$79.73
$32.75
Analyst Decision
Buy
Buy
Analyst Count
16
12
Target Price
$90.53
$50.75
AVG Volume (30 Days)
1.0M
2.7M
Earning Date
06-03-2026
05-06-2026
Dividend Yield
0.16%
N/A
EPS Growth
N/A
82.31
EPS
1.90
N/A
Revenue
$8,950,200,000.00
$24,000.00
Revenue This Year
$1.89
N/A
Revenue Next Year
$1.86
$33.77
P/E Ratio
$41.77
N/A
Revenue Growth
3.44
33.33
52 Week Low
$59.60
$15.60
52 Week High
$100.75
$38.26

Technical Indicators

Market Signals
Indicator
PVH
BEAM
Relative Strength Index (RSI) 52.13 48.29
Support Level $76.41 $23.83
Resistance Level $79.91 $35.18
Average True Range (ATR) 3.09 2.84
MACD 0.76 -0.06
Stochastic Oscillator 96.34 21.32

Price Performance

Historical Comparison
PVH
BEAM

About PVH PVH Corp.

PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites, roughly 1,400 standalone stores, and about 1,500 shop-in-shops and concessions. The firm also licenses its brands to third parties and distributes its merchandise through department stores and other wholesale accounts. PVH traces its history to 1881 and is based in New York City.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: